文献速递细菌感染、耐药与抗菌药物

美国加利福尼亚州圣迭戈2017-2020年抗菌药物耐药志贺菌属

Antimicrobial-Resistant Shigella spp. in San Diego, California, USA, 2017-2020.
PubMed 文献 · Emerg Infect Dis · 2022-01-01

该研究回顾性分析了美国加利福尼亚州圣迭戈2017-2020年确诊的128例福氏志贺菌和宋内志贺菌腹泻病例,发现多数病例为男男性行为者、HIV感染者、无住房者或使用甲基苯丙胺者,分离株对阿奇霉素、氟喹诺酮类、氨苄西林和甲氧苄啶/磺胺甲噁唑的耐药率分别为55%、23%、70%和83%,其中甲氧苄啶/磺胺甲噁唑耐药率略高于美国CDC最新全国数据。

要点

  • 128例可评估病例中福氏志贺菌略多于宋内志贺菌,多数为男男性行为者、HIV感染者、无住房者或使用甲基苯丙胺者。
  • 分离株对阿奇霉素耐药率55%、氟喹诺酮类23%、氨苄西林70%、甲氧苄啶/磺胺甲噁唑83%。
  • 甲氧苄啶/磺胺甲噁唑耐药率略高于美国CDC最新全国数据,其余药物耐药率与全国数据相当。

核心结论

  • 圣迭戈2017-2020年志贺菌分离株对阿奇霉素、氟喹诺酮类、氨苄西林和甲氧苄啶/磺胺甲噁唑的耐药率与CDC最新全国数据相当,但甲氧苄啶/磺胺甲噁唑耐药率略高于全国数据。

研究设计与样本

  • 回顾性分析美国加利福尼亚州圣迭戈2017-2020年诊断的福氏志贺菌和宋内志贺菌所致腹泻病例,共128例可评估病例。

主要发现

  • 128例可评估病例中福氏志贺菌略多于宋内志贺菌。
  • 多数病例为男男性行为者、HIV感染者、无住房者或使用甲基苯丙胺者。
  • 55%的分离株对阿奇霉素耐药,23%对氟喹诺酮类耐药,70%对氨苄西林耐药,83%对甲氧苄啶/磺胺甲噁唑耐药。
  • 甲氧苄啶/磺胺甲噁唑耐药率略高于CDC最新全国数据,其余药物耐药率与全国数据相当。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Annually, Shigella spp. cause ≈188 million cases of diarrheal disease globally, including 500,000 cases in the United States; rates of antimicrobial resistance are increasing. To determine antimicrobial resistance and risk factors in San Diego, California, USA, we retrospectively reviewed cases of diarrheal disease caused by Shigella flexneri and S. sonnei diagnosed during 2017-2020. Of 128 evaluable cases, S. flexneri was slightly more common than S. sonnei; most cases were in persons who were gay or bisexual cisgender men, were living with HIV, were unhoused, or used methamphetamines. Overall, rates of resistance to azithromycin, fluoroquinolones, ampicillin, and trimethoprim/sulfamethoxazole (TMP/SMX) were comparable to the most recent national data reported from the Centers for Disease Control and Prevention; 55% of isolates were resistant to azithromycin, 23% to fluoroquinolones, 70% to ampicillin, and 83% to TMP/SMX. The rates that we found for TMP/SMX were slightly higher than those in national data.

来源:Emerg Infect Dis,查看原文。版权归原作者所有。

引用

  1. Gaufin T, Blumenthal J, Ramirez-Sanchez C, et al. Antimicrobial-Resistant Shigella spp. in San Diego, California, USA, 2017-2020. Emerg Infect Dis. 2022. PMID: 35608550. doi:10.3201/eid2806.220131

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。